Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells
- 9 November 2000
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 19 (47) , 5385-5397
- https://doi.org/10.1038/sj.onc.1203911
Abstract
There have been few studies on the specific signaling pathways involved in the transformation of epithelial cells by oncogenic protein tyrosine kinases. Here we investigate the requirement of MAP (MAPK) and phosphatidylinositol 3- (PI3K) kinases in the transformation of rat intestinal epithelial (RIE) cells by oncogenic forms of insulin receptor (gag-IR), insulin-like growth factor-1 receptor (gag-IGFR), and v-Src. MAPK is not significantly activated in cells transformed by gag-IR and gag-IGFR but is activated in v-Src transformed cells. Treatment with PD98059, a MEK inhibitor, at concentrations where MAPK activity was reduced below the basal level showed that MAPK is partially required for the monolayer growth of parental and transformed RIE cells. However, MAPK is not essential for the focus forming ability of the three oncogene-transformed cells. It is also not necessary for the colony forming ability of gag-IR- and gag-IGFR-, but is partially required for v-Src-transformed cells. PI3K is significantly activated in all three oncogene transformed RIE cells. LY294002, a PI3K inhibitor, potently inhibited monolayer growth of all three oncogene-transformed cells. However, at concentrations of LY294002 where activated forms of Akt, a downstream component of the PI3K pathway, were undetectable, colony and focus forming abilities of the v-Src-RIE cells were only slightly affected whereas those of gag-IR/IGFR-RIE cells were greatly inhibited. These results were confirmed using a different pharmacological inhibitor, wortmannin, and a dominant negative form of PI3K, Δp85. Similarly, rapamycin, known to inhibit p70S6 kinase, a downstream component of the PI3K-Akt pathway, also inhibited gag-IR/IGFR-induced, but not v-Src-induced, focus and colony formation. We conclude that the MAPK and PI3K signaling pathways are differentially required for transformation of RIE cells by oncogenic IR and IGFR versus Src and the pattern of requirements is different from that of fibroblast transformation.Keywords
This publication has 49 references indexed in Scilit:
- Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanismOncogene, 1999
- Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascadeOncogene, 1998
- Effect of Dimerization on Signal Transduction and Biological Function of Oncogenic Ros, Insulin, and Insulin-like Growth Factor I ReceptorsPublished by Elsevier ,1997
- Src Phosphorylates the Insulin-like Growth Factor Type I Receptor on the Autophosphorylation SitesJournal of Biological Chemistry, 1996
- Role of c-Src Tyrosine Kinase in G Protein-coupled Receptorand Gβγ Subunit-mediated Activation of Mitogen-activated Protein KinasesJournal of Biological Chemistry, 1996
- Regulation, substrates and functions of srcBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- PH Domains: Diverse Sequences with a Common Fold Recruit Signaling Molecules to the Cell SurfaceCell, 1996
- Identification of Insulin and Insulin-like Growth Factor I (IGF I) Receptors in Ovarian Cancer TissueGynecologic Oncology, 1994
- Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Human cellular src gene product: Identification of the myristoylated pp60 and blockage of its myristoyl acylation with N-fatty acyl compounds resulted in the suppression of colony formationBiochemical and Biophysical Research Communications, 1990